A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma

Results from ACOSOG (Alliance) Z1072

Rache M. Simmons, Karla V. Ballman, Charles Cox, Ned Carp, Jennifer Sabol, Rosa F. Hwang, Deanna Attai, Michael Sabel, David Nathanson, Andrew Kenler, Linsey Gold, Cary Kaufman, Linda Han, Aaron Bleznak, J. Stanley Smith, Dennis Holmes, Bruno Fornage, Carisa Le-Petross, Syed Hoda, Linda McCall & 2 others Kelly K. Hunt, Behalf Of The Acosog Investigators On Behalf Of The Acosog Investigators

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Cryoablation is a well-established technique to treat fibroadenomas. Pilot studies suggest this could be an effective non-surgical treatment for breast cancer. American College of Surgeons Oncology Group Z1072 is a phase II trial exploring the effectiveness of cryoablation in the treatment of breast cancers. Methods: The primary endpoint of Z1072 was the rate of complete tumor ablation, defined as no remaining invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS) on pathologic examination of the targeted lesion. A secondary objective was to evaluate the negative predictive value of magnetic resonance imaging (MRI) to determine residual IBC or DCIS. Eligible patients included those with unifocal invasive ductal breast cancer ≤2 cm, with

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalAnnals of Surgical Oncology
DOIs
StateAccepted/In press - May 24 2016

Fingerprint

Cryosurgery
Breast Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Therapeutics
Fibroadenoma
Magnetic Resonance Imaging
Neoplasms

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Simmons, R. M., Ballman, K. V., Cox, C., Carp, N., Sabol, J., Hwang, R. F., ... On Behalf Of The Acosog Investigators, B. O. T. A. I. (Accepted/In press). A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072. Annals of Surgical Oncology, 1-8. https://doi.org/10.1245/s10434-016-5275-3

A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma : Results from ACOSOG (Alliance) Z1072. / Simmons, Rache M.; Ballman, Karla V.; Cox, Charles; Carp, Ned; Sabol, Jennifer; Hwang, Rosa F.; Attai, Deanna; Sabel, Michael; Nathanson, David; Kenler, Andrew; Gold, Linsey; Kaufman, Cary; Han, Linda; Bleznak, Aaron; Stanley Smith, J.; Holmes, Dennis; Fornage, Bruno; Le-Petross, Carisa; Hoda, Syed; McCall, Linda; Hunt, Kelly K.; On Behalf Of The Acosog Investigators, Behalf Of The Acosog Investigators.

In: Annals of Surgical Oncology, 24.05.2016, p. 1-8.

Research output: Contribution to journalArticle

Simmons, RM, Ballman, KV, Cox, C, Carp, N, Sabol, J, Hwang, RF, Attai, D, Sabel, M, Nathanson, D, Kenler, A, Gold, L, Kaufman, C, Han, L, Bleznak, A, Stanley Smith, J, Holmes, D, Fornage, B, Le-Petross, C, Hoda, S, McCall, L, Hunt, KK & On Behalf Of The Acosog Investigators, BOTAI 2016, 'A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072', Annals of Surgical Oncology, pp. 1-8. https://doi.org/10.1245/s10434-016-5275-3
Simmons, Rache M. ; Ballman, Karla V. ; Cox, Charles ; Carp, Ned ; Sabol, Jennifer ; Hwang, Rosa F. ; Attai, Deanna ; Sabel, Michael ; Nathanson, David ; Kenler, Andrew ; Gold, Linsey ; Kaufman, Cary ; Han, Linda ; Bleznak, Aaron ; Stanley Smith, J. ; Holmes, Dennis ; Fornage, Bruno ; Le-Petross, Carisa ; Hoda, Syed ; McCall, Linda ; Hunt, Kelly K. ; On Behalf Of The Acosog Investigators, Behalf Of The Acosog Investigators. / A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma : Results from ACOSOG (Alliance) Z1072. In: Annals of Surgical Oncology. 2016 ; pp. 1-8.
@article{259f9f6a2eca46d48b554f9b0fe99d8a,
title = "A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072",
abstract = "Background: Cryoablation is a well-established technique to treat fibroadenomas. Pilot studies suggest this could be an effective non-surgical treatment for breast cancer. American College of Surgeons Oncology Group Z1072 is a phase II trial exploring the effectiveness of cryoablation in the treatment of breast cancers. Methods: The primary endpoint of Z1072 was the rate of complete tumor ablation, defined as no remaining invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS) on pathologic examination of the targeted lesion. A secondary objective was to evaluate the negative predictive value of magnetic resonance imaging (MRI) to determine residual IBC or DCIS. Eligible patients included those with unifocal invasive ductal breast cancer ≤2 cm, with",
author = "Simmons, {Rache M.} and Ballman, {Karla V.} and Charles Cox and Ned Carp and Jennifer Sabol and Hwang, {Rosa F.} and Deanna Attai and Michael Sabel and David Nathanson and Andrew Kenler and Linsey Gold and Cary Kaufman and Linda Han and Aaron Bleznak and {Stanley Smith}, J. and Dennis Holmes and Bruno Fornage and Carisa Le-Petross and Syed Hoda and Linda McCall and Hunt, {Kelly K.} and {On Behalf Of The Acosog Investigators}, {Behalf Of The Acosog Investigators}",
year = "2016",
month = "5",
day = "24",
doi = "10.1245/s10434-016-5275-3",
language = "English (US)",
pages = "1--8",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",

}

TY - JOUR

T1 - A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma

T2 - Results from ACOSOG (Alliance) Z1072

AU - Simmons, Rache M.

AU - Ballman, Karla V.

AU - Cox, Charles

AU - Carp, Ned

AU - Sabol, Jennifer

AU - Hwang, Rosa F.

AU - Attai, Deanna

AU - Sabel, Michael

AU - Nathanson, David

AU - Kenler, Andrew

AU - Gold, Linsey

AU - Kaufman, Cary

AU - Han, Linda

AU - Bleznak, Aaron

AU - Stanley Smith, J.

AU - Holmes, Dennis

AU - Fornage, Bruno

AU - Le-Petross, Carisa

AU - Hoda, Syed

AU - McCall, Linda

AU - Hunt, Kelly K.

AU - On Behalf Of The Acosog Investigators, Behalf Of The Acosog Investigators

PY - 2016/5/24

Y1 - 2016/5/24

N2 - Background: Cryoablation is a well-established technique to treat fibroadenomas. Pilot studies suggest this could be an effective non-surgical treatment for breast cancer. American College of Surgeons Oncology Group Z1072 is a phase II trial exploring the effectiveness of cryoablation in the treatment of breast cancers. Methods: The primary endpoint of Z1072 was the rate of complete tumor ablation, defined as no remaining invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS) on pathologic examination of the targeted lesion. A secondary objective was to evaluate the negative predictive value of magnetic resonance imaging (MRI) to determine residual IBC or DCIS. Eligible patients included those with unifocal invasive ductal breast cancer ≤2 cm, with

AB - Background: Cryoablation is a well-established technique to treat fibroadenomas. Pilot studies suggest this could be an effective non-surgical treatment for breast cancer. American College of Surgeons Oncology Group Z1072 is a phase II trial exploring the effectiveness of cryoablation in the treatment of breast cancers. Methods: The primary endpoint of Z1072 was the rate of complete tumor ablation, defined as no remaining invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS) on pathologic examination of the targeted lesion. A secondary objective was to evaluate the negative predictive value of magnetic resonance imaging (MRI) to determine residual IBC or DCIS. Eligible patients included those with unifocal invasive ductal breast cancer ≤2 cm, with

UR - http://www.scopus.com/inward/record.url?scp=84970024580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970024580&partnerID=8YFLogxK

U2 - 10.1245/s10434-016-5275-3

DO - 10.1245/s10434-016-5275-3

M3 - Article

SP - 1

EP - 8

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

ER -